Clinical trial
An Investigational Study of MK0928 in Adult Outpatients With Insomnia…
NCT00103818 · H. Lundbeck A/S, Industry · Completed
Key facts
| NCT number | NCT00103818 |
|---|---|
| Title | An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED) |
| Official title | A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Efficacy Study of MK0928 15 mg and 10 mg in the Treatment of Adult Outpatients With Primary Insomnia |
| Lead sponsor | H. Lundbeck A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | gaboxadol, Comparator: placebo (unspecified) |
| Enrollment | 900 |
| Start date | Feb 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Feb 16, 2005 |
| Last update posted | Jan 14, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: